CRTC3 Antibody (Rabbit mAb) [M6H14]

Catalog No.: F5006

    Application: Reactivity:
    • Lane 1: MCF7, Lane 2: Hela, Lane 3: Jurkat
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    Application
    WB
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat, Monkey
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    70 kDa 76-78 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール MCF-7 cells; LN18 cells; SK-N-MC cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    CRTC3 Antibody (Rabbit mAb) [M6H14] detects endogenous levels of total CRTC3 protein.
    タンパク質の局在
    細胞質、細胞核
    Uniprot ID
    Q6UUV7
    Clone
    M6H14
    Synonym(s)
    CREB regulated transcription coactivator 3; CREB-regulated transcription coactivator 3; CRTC3; FLJ21868; TORC-3; TORC3
    Background
    CRTC3 (CREB‑regulated transcription coactivator 3) is a member of the CRTC family of CREB coactivators that links cAMP and Ca²⁺/stress signaling to transcriptional control of energy metabolism, catecholamine responsiveness, and inflammatory outputs, acting in a phosphorylation‑regulated, Ser133‑independent manner to potentiate CREB1 on both consensus and variant cAMP response elements. The protein contains an N‑terminal CREB‑binding domain with TORC‑conserved regions that dock onto the bZIP region of CREB1 and enhance its interaction with the TFIID subunit TAF4, and a C‑terminal serine‑rich transactivation domain that is heavily phosphorylated by salt‑inducible kinases (SIKs) and other kinases; phosphorylation promotes 14‑3‑3 binding and cytoplasmic retention, whereas dephosphorylation, often via PP2A‑B55 holoenzymes or phosphatases activated downstream of cAMP, calcium, or mitogens, releases CRTC3 to accumulate in the nucleus and coactivate CREB target genes. In adipocytes, CRTC3 is activated by catecholamine signaling through β‑adrenergic receptors in a manner that paradoxically dampens cAMP production: nuclear CRTC3 upregulates the regulator of G‑protein signaling RGS2, which terminates Gs signaling at the β‑adrenergic receptor level and attenuates adenylate cyclase activity, leading to reduced protein kinase A activation, blunted lipolysis, and suppression of thermogenic programs; this negative feedback positions CRTC3 as a transcriptional brake on catecholamine‑driven energy expenditure that promotes positive energy balance and susceptibility to obesity and insulin resistance. Human genetic analyses identify a gain‑of‑function CRTC3 variant associated with increased adiposity, and adipose‑tissue CRTC3 activity increases with high‑fat feeding and obesity, linking this coactivator to metabolic syndrome and making it a potential therapeutic target for enhancing brown and beige fat thermogenesis and improving systemic glucose homeostasis. Beyond adipocytes, CRTC3 acts as a selective coactivator for a subset of CREB‑dependent genes in multiple tissues: it cooperates with PPARGC1A to induce mitochondrial biogenesis in muscle cells, regulates steroidogenic genes such as StAR in endocrine contexts, and functions as a coactivator for HTLV‑1 Tax‑dependent transcription of viral long terminal repeats, integrating hormonal, metabolic, and viral signals at CREB‑controlled promoters and enhancers. In the immune system, phosphorylation of CRTC3 by SIKs in macrophages controls the interconversion between classically activated and regulatory phenotypes, with dephosphorylated CRTC3 entering the nucleus to enhance CREB‑driven IL‑10 production and modulate inflammatory tone, defining a SIK–CRTC3 axis that couples metabolic and stress cues to cytokine programming.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください